Perioperative levosimendan in cardiac surgery: A systematic review with meta-analysis and trial sequential analysis

International Journal of Cardiology

Volumn 251, Issue , 2018, Pages 22-31

  Putzu, Alessandro ^a   Clivio, Sara ^a   Belletti, Alessandro ^b   Cassina, Tiziano ^a  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cardiac surgery; Cardiology; Levosimendan; Meta analysis; Mortality; Systematic review

Indexed keywords

LEVOSIMENDAN; ANTIARRHYTHMIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ACUTE KIDNEY FAILURE; ARTICLE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HEART INFARCTION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; INCIDENCE; META ANALYSIS; MORTALITY RATE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SIDE EFFECT; SYSTEMATIC REVIEW; POSTOPERATIVE COMPLICATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-ARRHYTHMIA AGENTS; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDRAZONES; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85032919700     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.10.077     Document Type: Article

References (85)

1. A. Beckmann, A.-K. Funkat, J. Lewandowski, M. Frie, M. Ernst, K. Hekmat, W. Schiller, J.F. Gummert, J.T. Cremer, Cardiac Surgery in Germany during 2014: A report on behalf of the German Society for Thoracic and Cardiovascular Surgery, Thorac. Cardiovasc. Surg. 63 (2015) 258–69.
2. Benjamin, E.J., Blaha, M.J., Chiuve, S.E., Cushman, M., Das, S.R., Deo, R., de Ferranti, S.D., Floyd, J., Fornage, M., Gillespie, C., Isasi, C.R., Jiménez, M.C., Jordan, L.C., Judd, S.E., Lackland, D., Lichtman, J.H., Lisabeth, L., Liu, S., Longenecker, C.T., Mackey, R.H., Matsushita, K., Mozaffarian, D., Mussolino, M.E., Nasir, K., Neumar, R.W., Palaniappan, L., Pandey, D.K., Thiagarajan, R.R., Reeves, M.J., Ritchey, M., Rodriguez, C.J., Roth, G.A., Rosamond, W.D., Sasson, C., Towfighi, A., Tsao, C.W., Turner, M.B., Virani, S.S., Voeks, J.H., Willey, J.Z., Wilkins, J.T., Wu, J.H., Alger, H.M., Wong, S.S., Muntner, P., American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association. Circulation 135 (2017), e146–e603.
3. Denault, A.Y., Tardif, J.-C., Mazer, C.D., Lambert, J., Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study. J. Cardiothorac. Vasc. Anesth. 26 (2012), 608–616.
4. A. Mebazaa, A.A. Pitsis, A. Rudiger, W. Toller, D. Longrois, S.-E. Ricksten, I. Bobek, S. De Hert, G. Wieselthaler, U. Schirmer, L.K. von Segesser, M. Sander, D. Poldermans, M. Ranucci, P.C. Karpati, P. Wouters, M. Seeberger, E.R. Schmid, W. Weder, F. Follath, Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery, Crit. Care 14 (2010) 201.
5. Lomivorotov, V.V., Efremov, S.M., Kirov, M.Y., Fominskiy, E.V., Karaskov, A.M., Low-cardiac-output syndrome after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 31 (2017), 291–308.
6. K.D. Algarni, M. Maganti, T.M. Yau, et al., W.S. Pierce, T.H. Marwick, Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years, Ann. Thorac. Surg. 92 (2011) 1678–1684.
7. Maganti, M., Badiwala, M., Sheikh, A., Scully, H., Feindel, C., David, T.E., Rao, V., Predictors of low cardiac output syndrome after isolated mitral valve surgery. J. Thorac. Cardiovasc. Surg. 140 (2010), 790–796.
8. Gillies, M., Bellomo, R., Doolan, L., Buxton, B., Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery – a systematic literature review. Crit. Care, 9, 2005, 266.
9. Shahin, J., deVarennes, B., Tse, C., Amarica, D.-A., Dial, S., The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit. Care., 15, 2011 R162.
10. Fellahi, J.-L., Parienti, J.-J., Hanouz, J.-L., Plaud, B., Riou, B., Ouattara, A., Perioperative use of Dobutamine in cardiac surgery and adverse cardiac outcome. Anesthesiology 108 (2008), 979–987.
11. Papp, Z., Édes, I., Fruhwald, S., De Hert, S.G., Salmenperä, M., Leppikangas, H., Mebazaa, A., Landoni, G., Grossini, E., Caimmi, P., Morelli, A., Guarracino, F., Schwinger, R.H.G., Meyer, S., Algotsson, L., Wikström, B.G., Jörgensen, K., Filippatos, G., Parissis, J.T., González, M.J.G., Parkhomenko, A., Yilmaz, M.B., Kivikko, M., Pollesello, P., Follath, F., Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int. J. Cardiol. 159 (2012), 82–87.
12. Farmakis, D., Alvarez, J., Ben Gal, T., Brito, D., Fedele, F., Fonseca, C., Gordon, A.C., Gotsman, I., Grossini, E., Guarracino, F., Harjola, V.-P., Hellman, Y., Heunks, L., Ivancan, V., Karavidas, A., Kivikko, M., Lomivorotov, V., Longrois, D., Masip, J., Metra, M., Morelli, A., Nikolaou, M., Papp, Z., Parkhomenko, A., Poelzl, G., Pollesello, P., Ravn, H.B., Rex, S., Riha, H., Ricksten, S.-E., Schwinger, R.H.G., Vrtovec, B., Yilmaz, M.B., Zielinska, M., Parissis, J., Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. Int. J. Cardiol. 222 (2016), 303–312.
13. Nieminen, M.S., Fruhwald, S., Heunks, L.M.A., Suominen, P.K., Gordon, A.C., Kivikko, M., Pollesello, P., Levosimendan: current data, clinical use and future development. Hear. Lung Vessel. 5 (2013), 227–245.
14. Belletti, A., Castro, M.L., Silvetti, S., Greco, T., Biondi-Zoccai, G., Pasin, L., Zangrillo, A., Landoni, G., The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br. J. Anaesth. 115 (2015), 656–675.
15. Pollesello, P., Parissis, J., Kivikko, M., Harjola, V.-P., Levosimendan meta-analyses: is there a pattern in the effect on mortality?. Int. J. Cardiol. 209 (2016), 77–83.
16. Landoni, G., Biondi-Zoccai, G., Greco, M., Greco, T., Bignami, E., Morelli, A., Guarracino, F., Zangrillo, A., Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit. Care Med. 40 (2012), 634–646.
17. Harrison, R.W., Hasselblad, V., Mehta, R.H., Levin, R., Harrington, R.A., Alexander, J.H., Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J. Cardiothorac. Vasc. Anesth. 27 (2013), 1224–1232.
18. Greco, T., Calabrò, M.G., Covello, R.D., Greco, M., Pasin, L., Morelli, A., Landoni, G., Zangrillo, A., A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br. J. Anaesth. 114 (2015), 746–756.
19. G. Koster, J. Wetterslev, C. Gluud, J.G. Zijlstra, T.W.L. Scheeren, I.C.C. van der Horst, F. Keus, Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis., Intensive Care Med. 41 (2015) 203–21.
20. Landoni, G., Lomivorotov, V.V., Alvaro, G., Lobreglio, R., Pisano, A., Guarracino, F., Calabrò, M.G., Grigoryev, E.V., Likhvantsev, V.V., Salgado-Filho, M.F., Bianchi, A., Pasyuga, V.V., Baiocchi, M., Pappalardo, F., Monaco, F., Boboshko, V.A., Abubakirov, M.N., Amantea, B., Lembo, R., Brazzi, L., Verniero, L., Bertini, P., Scandroglio, A.M., Bove, T., Belletti, A., Michienzi, M.G., Shukevich, D.L., Zabelina, T.S., Bellomo, R., Zangrillo, A., CHEETAH Study Group, Levosimendan for Hemodynamic Support after Cardiac Surgery. N. Engl. J. Med., 2017, 2021–2031.
21. Mehta, R.H., Leimberger, J.D., van Diepen, S., Meza, J., Wang, A., Jankowich, R., Harrison, R.W., Hay, D., Fremes, S., Duncan, A., Soltesz, E.G., Luber, J., Park, S., Argenziano, M., Murphy, E., Marcel, R., Kalavrouziotis, D., Nagpal, D., Bozinovski, J., Toller, W., Heringlake, M., Goodman, S.G., Levy, J.H., Harrington, R.A., Anstrom, K.J., Alexander, J.H., LEVO-CTS investigators, levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N. Engl. J. Med., 2017, 2032–2042.
22. Cholley, B., Caruba, T., Grosjean, S., Amour, J., Ouattara, A., Villacorta, J., Miguet, B., Guinet, P., Lévy, F., Squara, P., Aït Hamou, N., Carillon, A., Boyer, J., Boughenou, M.-F., Rosier, S., Robin, E., Radutoiu, M., Durand, M., Guidon, C., Desebbe, O., Charles-Nelson, A., Menasché, P., Rozec, B., Girard, C., Fellahi, J.-L., Pirracchio, R., Chatellier, G., Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass. JAMA, 2017, 548–556.
23. Higgins, J.P., Green, S., Cochrane Handbook for systematic reviews of interventions, version 5. The Cochrane Collaboration, 2011.
24. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P.A., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, 2009, b2700.
25. A. Putzu, S. Clivio, T. Cassina, A. Belletti, Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis, PROSPERO Int. Prospect. Regist. Syst Rev. (2017). https://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID = CRD42017057677 (accessed March 8, 2017).
26. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med., 6, 2009, e1000097.
27. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C., Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J. Clin. Epidemiol. 61 (2008), 64–75.
28. Brok, J., Thorlund, K., Gluud, C., Wetterslev, J., Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J. Clin. Epidemiol. 61 (2008), 763–769.
29. Tritapepe, L., De Santis, V., Vitale, D., Santulli, M., Morelli, A., Nofroni, I., Puddu, P.E., Singer, M., Pietropaoli, P., Preconditioning effects of levosimendan in coronary artery bypass grafting–a pilot study. Br. J. Anaesth. 96 (2006), 694–700.
30. Tritapepe, L., De Santis, V., Vitale, D., Guarracino, F., Pellegrini, F., Pietropaoli, P., Singer, M., Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br. J. Anaesth. 102 (2009), 198–204.
31. Shah, B., Sharma, P., Brahmbhatt, A., Shah, R., Rathod, B., Shastri, N., Patel, J., Malhotra, A., Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study. Indian J. Pharmacol. 46 (2014), 29–34.
32. Sahu, M.K., Das, A., Malik, V., Subramanian, A., Singh, S.P., Hote, M., Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery. Ann. Card. Anaesth. 19 (2016), 52–58.
33. Salgado Filho, M.F., Barral, M., Barrucand, L., Cavalcanti, I.L., Verçosa, N., A randomized blinded study of the left ventricular myocardial performance index comparing epinephrine to levosimendan following cardiopulmonary bypass. PLoS One, 10, 2015, e0143315.
34. Nijhawan, N., Nicolosi, A.C., Montgomery, M.W., Aggarwal, A., Pagel, P.S., Warltier, D.C., Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J. Cardiovasc. Pharmacol. 34 (1999), 219–228.
35. Mishra, A., Kumar, B., Dutta, V., Arya, V.K., Mishra, A.K., Comparative effect of levosimendan and milrinone in cardiac surgery patients with pulmonary hypertension and left ventricular dysfunction. J. Cardiothorac. Vasc. Anesth. 30 (2016), 639–646.
36. Lomivorotov, V.V., Boboshko, V.A., Efremov, S.M., Kornilov, I.A., Chernyavskiy, A.M., Lomivorotov, V.N., Knazkova, L.G., Karaskov, A.M., Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. J. Cardiothorac. Vasc. Anesth. 26 (2012), 596–603.
37. Levin, R.L., Degrange, M.A., Porcile, R., Salvagio, F., Blanco, N., Botbol, A.L., Tanus, E., del Mazo, C.D., The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev. Esp. Cardiol. 61 (2008), 471–479.
38. Levin, R., Degrange, M., Del Mazo, C., Tanus, E., Porcile, R., Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp. Clin. Cardiol. 17 (2012), 125–130.
39. Lahtinen, P., Pitkänen, O., Pölönen, P., Turpeinen, A., Kiviniemi, V., Uusaro, A., Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit. Care Med. 39 (2011), 2263–2270.
40. Kodalli, R.K., Sundar, A.S., Vakamudi, M., Ravulapali, H., Nandipati, S., Chandrasekaran, N., Karthekeyan, R.B., Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: a randomized controlled study. Ann. Card. Anaesth. 16 (2013), 94–99.
41. Knezevic, I., Poglajen, G., Hrovat, E., Oman, A., Pintar, T., Wu, J.C., Vrtovec, B., Haddad, F., The effects of levosimendan on renal function early after heart transplantation: results from a pilot randomized trial. Clin. Transpl. 28 (2014), 1105–1111.
42. Järvelä, K., Maaranen, P., Sisto, T., Ruokonen, E., Levosimendan in aortic valve surgery: cardiac performance and recovery. J. Cardiothorac. Vasc. Anesth. 22 (2008), 693–698.
43. Juhl-Olsen, P., Jakobsen, C.-J., Rasmussen, L.A., Bhavsar, R., Klaaborg, K.-E., Frederiksen, C.A., Sloth, E., Effects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement. Acta Anaesthesiol. Scand. 59 (2015), 65–77.
44. Ersoy, O., Boysan, E., Unal, E.U., Yay, K., Yener, U., Cicekcioglu, F., Katircioglu, F., Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc. J. Afr. 24 (2013), 260–264.
45. Gandham, R., Syamasundar, A., Ravulapalli, H., Karthekeyan, R.B., Vakamudi, M., Kodalli, R., Nandipati, S., A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair/replacement for severe mitral stenosis. Ann. Card. Anaesth. 16 (2013), 11–15.
46. Eriksson, H.I., Jalonen, J.R., Heikkinen, L.O., Kivikko, M., Laine, M., Leino, K.A., Kuitunen, A.H., Kuttila, K.T., Peräkylä, T.K., Sarapohja, T., Suojaranta-Ylinen, R.T., Valtonen, M., Salmenperä, M.T., Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann. Thorac. Surg. 87 (2009), 448–454.
47. Erb, J., Beutlhauser, T., Feldheiser, A., Schuster, B., Treskatsch, S., Grubitzsch, H., Spies, C., Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J. Int. Med. Res. 42 (2014), 750–764.
48. De Hert, S.G., Lorsomradee, S., Cromheecke, S., Van der Linden, P.J., The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth. Analg. 104 (2007), 766–773.
49. Bragadottir, G., Redfors, B., Ricksten, S.-E., Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit. Care Med. 41 (2013), 2328–2335.
50. Baysal, A., Yanartas, M., Dogukan, M., Gundogus, N., Kocak, T., Koksal, C., Levosimendan improves renal outcome in cardiac surgery: a randomized trial. J. Cardiothorac. Vasc. Anesth. 28 (2014), 586–594.
51. Barisin, S., Husedzinovic, I., Sonicki, Z., Bradic, N., Barisin, A., Tonkovic, D., Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J. Cardiovasc. Pharmacol. 44 (2004), 703–708.
52. Asaad, O.M., Hanafy, M.S., Levosimendan's effect on coronary artery grafts blood flow in patients with left ventricular dysfunction, assessment by transit time flow meter. Egypt. J. Anaesth. 27 (2011), 45–53.
53. Anastasiadis, K., Antonitsis, P., Vranis, K., Kleontas, A., Asteriou, C., Grosomanidis, V., Tossios, P., Argiriadou, H., Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study. Interact. Cardiovasc. Thorac. Surg. 23 (2016), 740–747.
54. Alvarez, J., Bouzada, M., Fernández, A.L., Caruezo, V., Taboada, M., Rodríguez, J., Ginesta, V., Rubio, J., García-Bengoechea, J.B., González-Juanatey, J.R., Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev. Esp. Cardiol. 59 (2006), 338–345.
55. Al-Shawaf, E., Ayed, A., Vislocky, I., Radomir, B., Dehrab, N., Tarazi, R., Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J. Cardiothorac. Vasc. Anesth. 20 (2006), 353–357.
56. Abacilar, A.F., Dogan, O.F., Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg. Forum., 16, 2013 E287–94.
57. Plotnikov, G., Shukevich, D., Geyze, A., Grigoryev, E., Sizova, I., Preoperative variations assessment in patients with low ejection fraction. Clin. Anesthesiol. Intensive Care., 2013, 50–59.
58. Levin, R., Degrange, M., Del-Mazo, C., Porcile, R., Tanus, E., Blanco, N., Salvagio, F., Botbol, L., Milman, V., Superiority of levosimendan over dobutamine in low cardiac output syndrome after aortic valve replacement. Circulation, 118, 2008, e231.
59. Levin, R., Degrange, M., Porcile, R., Salvagio, F., Del Mazo, C., Tanus, E., Blanco, N., Botbol, L., Preoperative use of calcium sensitizer Levosimendan reduces mortality and low cardiac output syndrome in patients with aortic stenosis and left ventricular dysfunction. Circulation, 118, 2008, E217.
60. Levin, R., Degrange, M., Porcile, R., Salvagio, F., Blanco, N., Botbol, L., The preoperative utilization of levosimendan (preoperative optimization) reduced mortality in low cardiac output syndrome after cardiac surgery in patients with low ejection fraction (EF < 25%). Circulation, 116, 2007, 682.
61. Leppikangas, H., Jarvela, K., Sisto, T., Maaranen, P., Virtanen, M., Lehto, P., Karlsson, S., Koobi, T., Lindgren, L., Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br. J. Anaesth. 106 (2011), 298–304.
62. Bautin, A., Efficacy of levosimendan pretreatment in high-risk cardiac surgery patients. Interact. Cardiovasc. Thorac. Surg. 12 (2011), iv–xxiii.
63. Kandasamy, A., Simon, H.A., Murthy, P., Annadurai, M., Ali, M.M., Ramanathan, G., Comparison of levosimendan versus dobutamine in patients with moderate to severe left ventricular dysfunction undergoing off-pump coronary artery bypass grafting: a randomized prospective study. Ann. Card. Anaesth. 20 (2017), 200–206.
64. Atalay, H., Temizturk, Z., Altinsoy, H.B., Azboy, D., Colak, S., Atalay, A., Dogan, O.F., Levosimendan use increases cardiac performance after coronary artery bypass grafting in end-stage renal disease patients. Hear. Surg Forum. 19 (2016), 230–236.
65. Ristikankare, A., Pöyhiä, R., Eriksson, H., Valtonen, M., Leino, K., Salmenperä, M., Effects of levosimendan on renal function in patients undergoing coronary artery surgery. J. Cardiothorac. Vasc. Anesth. 26 (2012), 591–595.
66. Sharma, P., Malhotra, A., Gandhi, S., Garg, P., Bishnoi, A., Gandhi, H., Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc. Thorac. Ann. 22 (2014), 539–545.
67. O'Neal, J.B., Shaw, A.D., Billings, F.T., Acute kidney injury following cardiac surgery: current understanding and future directions. Crit. Care, 20, 2016, 187.
68. M.B. Yilmaz, E. Grossini, J.C. Silva Cardoso, I. Édes, F. Fedele, P. Pollesello, M. Kivikko, V.-P. Harjola, J. Hasslacher, A. Mebazaa, A. Morelli, J. le Noble, A. Oldner, I. Oulego Erroz, J.T. Parissis, A. Parkhomenko, G. Poelzl, S. Rehberg, S.-E. Ricksten, L.M. Rodríguez Fernández, M. Salmenperä, M. Singer, S. Treskatsch, B. Vrtovec, G. Wikström, Renal effects of levosimendan: a consensus report., Cardiovasc. Drugs Ther. 27 (2013) 581–90.
69. Bove, T., Matteazzi, A., Belletti, A., Paternoster, G., Saleh, O., Taddeo, D., Dossi, R., Greco, T., Bradic, N., Husedzinovic, I., Nigro Neto, C., Lomivorotov, V.V., Calabrò, M.G., Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 7 (2015), 35–46.
70. Zhou, C., Gong, J., Chen, D., Wang, W., Liu, M., Liu, B., Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am. J. Kidney Dis. 67 (2016), 408–416.
71. LaPar, D.J., Speir, A.M., Crosby, I.K., Fonner, E., Brown, M., Rich, J.B., Quader, M., Kern, J.A., Kron, I.L., Ailawadi, G., Investigators for the Virginia cardiac surgery quality initiative, postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. Ann. Thorac. Surg. 98 (2014), 527–533.
72. Filardo, G., Hamilton, C., Hamman, B., Hebeler, R.F., Adams, J., Grayburn, P., New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann. Thorac. Surg. 90 (2010), 474–479.
73. Antila, S., Sundberg, S., Lehtonen, L.A., Clinical pharmacology of levosimendan. Clin. Pharmacokinet. 46 (2007), 535–552.
74. Antila, S., Pesonen, U., Lehtonen, L., Tapanainen, P., Nikkanen, H., Vaahtera, K., Scheinin, H., Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators. Eur. J. Pharm. Sci. 23 (2004), 213–222.
75. Lilleberg, J., Laine, M., Palkama, T., Kivikko, M., Pohjanjousi, P., Kupari, M., Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur. J. Heart Fail. 9 (2007), 75–82.
76. Slawsky, M.T., Colucci, W.S., Gottlieb, S.S., Greenberg, B.H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C.V., LeJemtel, T.H., Loh, E., Nicklas, J., Ogilby, D., Singh, B.N., Smith, W., Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 102 (2000), 2222–2227.
77. Kivikko, M., Lehtonen, L., Colucci, W.S., Sustained hemodynamic effects of intravenous levosimendan. Circulation 107 (2003), 81–86.
78. Gordon, A.C., Perkins, G.D., Singer, M., McAuley, D.F., Orme, R.M.L., Santhakumaran, S., Mason, A.J., Cross, M., Al-Beidh, F., Best-Lane, J., Brealey, D., Nutt, C.L., McNamee, J.J., Reschreiter, H., Breen, A., Liu, K.D., Ashby, D., Levosimendan for the prevention of acute organ dysfunction in sepsis. N. Engl. J. Med., 2016, 1638–1648.
79. Andreis, D.T., Singer, M., Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 42 (2016), 1387–1397.
80. Higgins, J.P.T., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Savovic, J., Schulz, K.F., Weeks, L., Sterne, J.A.C., The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
81. Wood, L., Egger, M., Gluud, L.L., Schulz, K.F., Juni, P., Altman, D.G., Gluud, C., Martin, R.M., Wood, A.J.G., Sterne, J.A.C., Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336 (2008), 601–605.
82. Page, M.J., Higgins, J.P.T., Clayton, G., Sterne, J.A.C., Hróbjartsson, A., Savović, J., Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies. PLoS One, 11, 2016, e0159267.
83. Savović, J., Jones, H.E., Altman, D.G., Harris, R.J., Jüni, P., Pildal, J., Als-Nielsen, B., Balk, E.M., Gluud, C., Gluud, L.L., Ioannidis, J.P.A., Schulz, K.F., Beynon, R., Welton, N.J., Wood, L., Moher, D., Deeks, J.J., Sterne, J.A.C., Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann. Intern. Med., 157, 2012, 429.
84. Hopewell, S., Loudon, K., Clarke, M.J., Oxman, A.D., Dickersin, K., Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst. Rev., 2009 MR000006.
85. Zhang, Z., Xu, X., Ni, H., Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit. Care, 17, 2013, R2.